Safi Shahda MD

PubMed

• Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.
  Gentry G King, Kelsey K Baker, Andrew L Coveler, William P Harris, Stacey A Cohen
  Cancers. 2025-05-30
• 44 citations
  Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
  Xiaoling Zhong, Ashok Narasimhan, Libbie M Silverman, Andrew R Young, Safi Shahda
  Journal of Cachexia, Sarcopenia and Muscle. 2022-08-01
• 19 citations
  A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
  Cameron Herting, Matthew R. Farren, Yan Tong, Ziyue Liu, Bert H. O'Neil
  Cancer Immunology, Immunotherapy. 2021-06-23

Journal Articles

• Phase I Study of EUS-Guided Photodynamic Therapy for Locally Advanced Pancreatic Cancer  
  John M Dewitt, Bert O'Neil, Amikar Sehdev, Safi Shahda, Gastrointestinal Endoscopy
• Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX  
  Olumide Gbolahan, Amikar Sehdev, Howard H Wu, Safi Shahda, Clinical Cancer Research

Lectures

• A phase I study of the APE1 protein inhibitor APX3330 in patients with advanced solid tumors. 
  2019 ASCO Annual Meeting - 6/1/2019
• Prospective trial of preoperative FOLFIRINOX in patients with resectable pancreatic ductal adenocarcinoma (PDAC): Report of early endpoints. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018